Histamine modulates microglia function

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Ferreira, Raquel ^a   Santos, Tiago ^a   Gonçalves, Joana ^b   Baltazar, Graça ^c   Ferreira, Lino ^a,d   Agasse, Fabienne ^a   Bernardino, Liliana ^a,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^d Biocant Biotechnology Innovation Center   (Portugal)

Author keywords

Histamine; Histamine 4 receptor; Inflammation; Microglia; Migration

Indexed keywords

HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; INTERLEUKIN 1BETA; POLYGLACTIN; PROTEIN KINASE B; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL MIGRATION; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; MEDIATOR RELEASE; MICROGLIA; NERVE CELL CULTURE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84860618694     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-90     Document Type: Article

References (45)

1. Garden G, Möller T. Microglia biology in health and disease. J Neuroimmune Pharmacol 2006, 1:127-137. 10.1007/s11481-006-9015-5, 18040779.
2. Block ML, Zecca L, Hong J-S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurol 2007, 8:57-69.
3. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav Immun 2003, 17:13-19. 10.1016/S0889-1591(02)00055-7, 12615045.
4. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891.
5. Kinet JP. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 1999, 17:931-972. 10.1146/annurev.immunol.17.1.931, 10358778.
6. Katoh Y, Niimi M, Yamamoto Y, Kawamura T, Morimoto-Ishizuka T, Sawada M, Takemori H, Yamatodani A. Histamine production by cultured microglial cells of the mouse. Neurosci Lett 2001, 305:181-184. 10.1016/S0304-3940(01)01835-3, 11403935.
7. Dy M, Schneider E. Histamine-cytokine connection in immunity and hematopoiesis. Cytokine Growth Factor Rev 2004, 15:393-410. 10.1016/j.cytogfr.2004.06.003, 15450254.
8. Zampeli E, Tiligada E. The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol 2009, 157:24-33. 10.1111/j.1476-5381.2009.00151.x, 2697784, 19309354.
9. de Esch IJ, Thurmond RL, Jongejan A, Leurs R. The histamine H4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci 2005, 26:462-469.
10. Ferreira R, Xapelli S, Santos T, Silva AP, Cristovao A, Cortes L, Malva JO. Neuropeptide Y modulation of interleukin-1 beta (IL-1β)-induced nitric oxide production in microglia. J Biol Chem 2010, 285:41921-41934. 10.1074/jbc.M110.164020, 3009919, 20959451.
11. Saura J, Tusell JM, Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia 2003, 44:183-189. 10.1002/glia.10274, 14603460.
12. Ferreira LS, Gerecht S, Fuller J, Shieh HF, Vunjak-Novakovic G. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 2007, 28:2706-2717. 10.1016/j.biomaterials.2007.01.021, 1903348, 17346788.
13. Bernardino L, Eiriz MF, Santos T, Xapelli S, Grade S, Rosa A, Cortes L, Ferreira R, Bragança J, Agasse F, et al. Histamine stimulates neurogenesis in the rodent subventricular zone. Stem Cells 2012, 30:773-784.
14. Valster A, Tran NL, Nakada M, Berens ME, Chan AY, Symons M. Cell migration and invasion assays. Methods 2005, 37:208-215. 10.1016/j.ymeth.2005.08.001, 16288884.
15. Ferreira R, Santos T, Viegas M, Cortes L, Bernardino L, Vieira OV, Malva JO. Neuropeptide Y inhibits interleukin-1beta-induced phagocytosis by microglial cells. J Neuroinflammation 2011, 8:169. 10.1186/1742-2094-8-169, 3239417, 22136135.
16. Ferreira R, Santos T, Cortes L, Cochaud S, Agasse F, Silva AP, Xapelli S, Malva JO. Neuropeptide Y inhibits interleukin-1 beta (IL-1β)-induced microglia motility. J Neurochem 2012, 120:93-105. 10.1111/j.1471-4159.2011.07541.x, 22007767.
17. Bustin S. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000, 25:169-193. 10.1677/jme.0.0250169, 11013345.
18. Strakhova MI, Nikkel AL, Manelli AM, Hsieh GC, Esbenshade TA, Brioni JD, Bitner RS. Localization of histamine H4 receptors in the central nervous system of human and rat. Brain Res 2009, 1250:41-48.
19. Connelly WM, Shenton FC, Lethbridge N, Leurs R, Waldvogel HJ, Faull RL, Lees G, Chazot PL. The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. Br J Pharmacol 2009, 157:55-63. 10.1111/j.1476-5381.2009.00227.x, 2697783, 19413571.
20. Vetvicka V, Hanikyrova M, Vetvickova J, Ross GD. Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules. Clin Exp Immunol 1999, 115:229-235. 10.1046/j.1365-2249.1999.00800.x, 1905157, 9933447.
21. Fletcher DA, Mullins RD. Cell mechanics and the cytoskeleton. Nature 2010, 463:485-492. 10.1038/nature08908, 2851742, 20110992.
22. Parsons JT, Horwitz AR, Schwartz MA. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol 2010, 11:633-643. 10.1038/nrm2957, 2992881, 20729930.
23. Desai P, Thurmond RL. Histamine H receptor activation enhances LPS-induced IL-6 production in mast cells via ERK and PI3K activation. Eur J Immunol 2011, 41:1764-1773. 10.1002/eji.201040932, 21469095.
24. Horvath RJ, DeLeo JA. Morphine enhances microglial migration through modulation of P2X4 receptor signaling. J Neurosci 2009, 29:998-1005. 10.1523/JNEUROSCI.4595-08.2009, 2727471, 19176808.
25. Martin S, Vincent JP, Mazella J. Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. J Neurosci 2003, 23:1198-1205.
26. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007, 10:1387-1394. 10.1038/nn1997, 17965659.
27. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev 2008, 88:1183-1241. 10.1152/physrev.00043.2007, 18626069.
28. Perry VH, Nicoll JAR, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol 2010, 6:193-201. 10.1038/nrneurol.2010.17, 20234358.
29. Buckland KF, Williams TJ, Conroy DM. Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor. Br J Pharmacol 2003, 140:1117-1127. 10.1038/sj.bjp.0705530, 1574117, 14530216.
30. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. Cell migration: integrating signals from front to back. Science 2003, 302:1704-1709. 10.1126/science.1092053, 14657486.
31. Nasu-Tada K, Koizumi S, Inoue K. Involvement of beta1 integrin in microglial chemotaxis and proliferation on fibronectin: different regulations by ADP through PKA. Glia 2005, 52:98-107. 10.1002/glia.20224, 15920726.
32. Jin YJ, Park I, Hong IK, Byun HJ, Choi J, Kim YM, Lee H. Fibronectin and vitronectin induce AP-1-mediated matrix metalloproteinase-9 expression through integrin alpha(5)beta(1)/alpha(v)beta(3)-dependent Akt, ERK and JNK signaling pathways in human umbilical vein endothelial cells. Cell Signal 2011, 23:125-134. 10.1016/j.cellsig.2010.08.012, 20816750.
33. Hague A, Jones GE. Cell motility assays. Cell Biol Toxicol 2008, 24:381-389. 10.1007/s10565-007-9049-3, 18071914.
34. Matsuo M, Sakurai H, Ueno Y, Ohtani O, Saiki I. Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: a novel functional target for gefitinib. Canc Sci 2006, 97:155-162.
35. Wang HQ, Bai L, Shen BR, Yan ZQ, Jiang ZL. Coculture with endothelial cells enhances vascular smooth muscle cell adhesion and spreading via activation of beta1-integrin and phosphatidylinositol 3-kinase/Akt. Eur J Cell Biol 2007, 86:51-62. 10.1016/j.ejcb.2006.09.001, 17141917.
36. Zhu H, Liu XW, Cai TY, Cao J, Tu CX, Lu W, He QJ, Yang B. Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway. J Pharmacol Exp Ther 2010, 334:489-499. 10.1124/jpet.110.165654, 20472666.
37. Furundzija V, Fritzsche J, Kaufmann J, Meyborg H, Fleck E, Kappert K, Stawowy P. IGF-1 increases macrophage motility via PKC/p38-dependent αvβv3-integrin inside-out signaling. Biochem Biophys Res Commun 2010, 394:786-791. 10.1016/j.bbrc.2010.03.072, 20230795.
38. Smits RA, Lim HD, Hanzer A, Zuiderveld OP, Guaita E, Adami M, Coruzzi G, Leurs R, de Esch IJ. Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo. J Med Chem 2008, 51:2457-2467. 10.1021/jm7014217, 18357976.
39. Morgan RK, McAllister B, Cross L, Green DS, Kornfeld H, Center DM, Cruikshank WW. Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model. J Immunol 2007, 178:8081-8089.
40. Osna N, Elliott K, Khan MM. Regulation of interleukin-10 secretion by histamine in TH2 cells and splenocytes. Int Immunopharmacol 2001, 1:85-96. 10.1016/S0162-3109(00)00268-X, 11367520.
41. Adachi N, Liu K, Motoki A, Nishibori M, Arai T. Suppression of ischemia/reperfusion liver injury by histamine H4 receptor stimulation in rats. Eur J Pharmacol 2006, 544:181-187. 10.1016/j.ejphar.2006.06.053, 16860312.
42. Basu A, Krady JK, O'Malley M, Styren SD, DeKosky ST, Levison SW. The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. J Neurosci 2002, 22:6071-6082.
43. Rowe J, Finlay-Jones JJ, Nicholas TE, Bowden J, Morton S, Hart PH. Inability of histamine to regulate TNF-alpha production by human alveolar macrophages. Am J Respir Cell Mol Biol 1997, 17:218-226.
44. Sirois J, Menard G, Moses AS, Bissonnette EY. Importance of histamine in the cytokine network in the lung through H2 and H3 receptors: stimulation of IL-10 production. J Immunol 2000, 164:2964-2970.
45. Morichika T, Takahashi HK, Iwagaki H, Yoshino T, Tamura R, Yokoyama M, Mori S, Akagi T, Nishibori M, Tanaka N. Histamine inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in an intercellular adhesion molecule-1- and B7.1-dependent manner. J Pharmacol Exp Ther 2003, 304:624-633. 10.1124/jpet.102.042515, 12538815.